CalciMedica, Inc. (CALC) Dividend History

CalciMedica, Inc. is a biotechnology company focused on developing therapies that target calcium signaling pathways involved in inflammatory and immune responses. Their innovative treatments aim to address diseases such as acute respiratory distress syndrome (ARDS), inflammatory bowel disease, and other immune-related conditions. The company leverages cutting-edge research to develop novel solutions to improve patient outcomes.

505 Coast Boulevard South, La Jolla, CA, 92037
Phone: 858-952-5500
Website:

Dividend History

CalciMedica, Inc. currently does not pay dividends

Company News

  • Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.

    Zacks Investment Research
    Featured Companies: ALC
  • The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. CalciMedica The Trade: CalciMedica, Inc. (NASDAQ: CALC) Chief Business Officer Eric W Roberts acquired a total of 4,000 shares an average price of $3.90. To acquire these shares, it cost around $15,600. What’s Happening: On March 28, CalciMedica posted a fourth-quarter loss of 23 cents ...

    Benzinga
    Featured Companies: RCG TGEN
  • As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. PepGen Inc. (NASDAQ: PEPG) On Jan. 8, PepGen said First Patient was dosed in CONNECT1-EDO51 Phase 2 clinical trial of PGN-EDO51 for duchenne muscular dystrophy patients amenable to Exon 51 skipping. The company’s stock ...

    Benzinga
    Featured Companies: FGEN ORMP PEPG
  • The Dow Jones closed higher by around 35 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Local Bounti The Trade: Local Bounti Corporation (NYSE: LOCL) Chief Technology Officer Travis M Joyner acquired a total of 4,220 shares an average price of $2.37. To acquire these shares, it cost around $10,000. The company’s CFO also bought 2,000 shares. What’s Happening: Deutsche Bank recently downgraded Local Bounti from Buy to Hold and lowered ...

    Benzinga
    Featured Companies: GCI LOCL
  • Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. FaZe Holdings Inc. (NASDAQ: FAZE) gained 46.9% to $0.2247 after falling over 4% on Friday. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares climbed 23.5% to $0.1472 after gaining 16% on Friday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose) on Sept. 12. Biophytis S.A. (NASDAQ: BPTS) shares gained 22.3% to $1.1250 after the company and Skyepharma announced the signature of a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19. Cano Health, Inc. (NYSE: CANO) rose 20.5% to $0.2727. Sharps Technology, Inc. (NASDAQ: STSS) surged 18.2% to $0.6703. CalciMedica, Inc. (NASDAQ: CALC) climbed 16.3% to $3.0699. TradeUP Acquisition Corp. (NASDAQ: UPTD) gained 14% to $14.50 So-Young International Inc. (NASDAQ: SY) gained 13.5% to $1.2263. Shattuck Labs, Inc. (NASDAQ: STTK) rose 13.3% to $1.71. Pasithea Therapeutics Corp. (NASDAQ: KTTA) gained 13.1% to $0.4998. Enthusiast Gaming Holdings Inc. (NASDAQ: EGLX) gained 12.7% to $0.3367. InnSuites Hospitality Trust (NYSE: IHT) surged 12.5% to $1.4399. Canopy Growth Corporation (NASDAQ: CGC) rose 12.5% to $0.9422. ESS Tech, Inc. (NYSE: GWH) shares climbed 10.1% to $1.53. Honeywell International Inc (NASDAQ: HON) entered into a strategic collaboration with ESS Tech to advance technology development and market adoption of iron flow battery (IFB) energy storage systems. Solo Brands, Inc. (NYSE: DTC) gained 10% to $4.9605. ...

    Benzinga
Dividend data last updated 06/07/2025 01:07:17 UTC